N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide

C38H39F4N9O4 — CID 176641094

IUPACN-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide
SMILESCn1c(=O)n(C2CCC(=O)NC2=O)c2cccc([C@@H]3CCN(CC4CCC(n5cc6cc(NC(=O)c7cc(C(F)(F)F)cnn7)ccc6n5)CC4)C[C@H]3F)c21
InChIInChI=1S/C38H39F4N9O4/c1-48-34-27(3-2-4-31(34)51(37(48)55)32-11-12-33(52)45-36(32)54)26-13-14-49(20-28(26)39)18-21-5-8-25(9-6-21)50-19-22-15-24(7-10-29(22)47-50)44-35(53)30-16-23(17-43-46-30)38(40,41)42/h2-4,7,10,15-17,19,21,25-26,28,32H,5-6,8-9,11-14,18,20H2,1H3,(H,44,53)(H,45,52,54)/t21?,25?,26-,28+,32?/m0/s1
InChIKeyMXBBUZWQWNQQIM-QURPJMLFSA-N
MW761.78 g/mol
LogP5.29
Rot. Bonds7

About N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide

N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide (PubChem CID 176641094) has the molecular formula C38H39F4N9O4 and a molecular weight of 761.78 g/mol. Its IUPAC name is N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide
PubChem CID176641094
Molecular FormulaC38H39F4N9O4
Molecular Weight761.78 g/mol
Exact Mass761.31
IUPAC NameN-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide
SMILESCn1c(=O)n(C2CCC(=O)NC2=O)c2cccc([C@@H]3CCN(CC4CCC(n5cc6cc(NC(=O)c7cc(C(F)(F)F)cnn7)ccc6n5)CC4)C[C@H]3F)c21
InChIInChI=1S/C38H39F4N9O4/c1-48-34-27(3-2-4-31(34)51(37(48)55)32-11-12-33(52)45-36(32)54)26-13-14-49(20-28(26)39)18-21-5-8-25(9-6-21)50-19-22-15-24(7-10-29(22)47-50)44-35(53)30-16-23(17-43-46-30)38(40,41)42/h2-4,7,10,15-17,19,21,25-26,28,32H,5-6,8-9,11-14,18,20H2,1H3,(H,44,53)(H,45,52,54)/t21?,25?,26-,28+,32?/m0/s1
InChIKeyMXBBUZWQWNQQIM-QURPJMLFSA-N
XLogP5.29
TPSA149.04 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms55
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500761.78
LogP ≤ 55.29
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide?
The IUPAC name of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide (CID 176641094) is N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide.
What is the SMILES notation for N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide?
The canonical SMILES for N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide is Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc([C@@H]3CCN(CC4CCC(n5cc6cc(NC(=O)c7cc(C(F)(F)F)cnn7)ccc6n5)CC4)C[C@H]3F)c21.
What is the InChIKey of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide?
The InChIKey is MXBBUZWQWNQQIM-QURPJMLFSA-N. The full InChI is InChI=1S/C38H39F4N9O4/c1-48-34-27(3-2-4-31(34)51(37(48)55)32-11-12-33(52)45-36(32)54)26-13-14-49(20-28(26)39)18-21-5-8-25(9-6-21)50-19-22-15-24(7-10-29(22)47-50)44-35(53)30-16-23(17-43-46-30)38(40,41)42/h2-4,7,10,15-17,19,21,25-26,28,32H,5-6,8-9,11-14,18,20H2,1H3,(H,44,53)(H,45,52,54)/t21?,25?,26-,28+,32?/m0/s1.
What are the key properties of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide?
N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide has a molecular weight of 761.78 g/mol, XLogP of 5.29, 7 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-5-(trifluoromethyl)pyridazine-3-carboxamide is sourced from PubChem (CID 176641094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).